Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2002
08/13/2002US6433025 Method for retarding and preventing sunburn by UV light
08/13/2002US6433024 Topical anti-acne composition
08/13/2002US6433023 Compositions having anti-leishmanial activity
08/13/2002US6433022 Exposure of semen to naphthoquinone/1,4-/ or juglone; reduction to semiquinone and generation of oxygen, superoxide, hydrogen peroxide, or free radicals; immobilization
08/13/2002US6433021 Antiinflammatory agents; mast cell stabilizers
08/13/2002US6433020 1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutylamine derivatives are administered to prevent carotid intimal medial thickening; dyslipidemia treatment
08/13/2002US6433019 Administering a nitric oxide donor to treat neurodegenerative disorders
08/13/2002US6433018 Method for reducing hypertrophy and ischemia
08/13/2002US6433015 Administering a given dosage of creatine
08/13/2002US6433014 1-aminocyclopentane-1-carboxylic acid derivative glutamatergic receptor agonists and antagonists; central nervous system disorders; alzheimer*s and parkinson*s disease treatment
08/13/2002US6433012 Administering methyl diiodo-benzoate derivatives as angiogenesis inhibitors; reducing tumor necrosis factor; treating inflammatory bowel and crohn*s disease
08/13/2002US6433011 Method for inhibiting formation of aberrant crypt foci in the colon of a mammal
08/13/2002US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents
08/13/2002US6433008 Treating parkinson*s, alzheimer*s, autoimmune and rheumatic diseases; human immunodeficiency virus (hiv) dementia, and inflammation
08/13/2002US6433007 Methods for the prevention and treatment of post-surgical complications
08/13/2002US6433006 Method of treatment of seborrheic dermatitis
08/13/2002US6433005 Selective cox ii inhibitor
08/13/2002US6433004 Substituted β,γ-anellated lactones
08/13/2002US6433003 Topically administering glycopyrrolate to prevent sweating; side effect reduction
08/13/2002US6433001 1H-indole-3-glyoxylamide sPLA2 inhibitors
08/13/2002US6433000 Aromatic sulfamate derivatives as sulfatase inhibitors; estrogen receptor blockers; breast cancer treatment
08/13/2002US6432996 Pharmaceutical composition
08/13/2002US6432995 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor from cells
08/13/2002US6432994 Cardiovascular disorders, glaucoma; antiinflammatory, wound healing, hypotensive, antiasthmatic, and antianaphylactic agents
08/13/2002US6432993 Substituted fused heterocyclic compound
08/13/2002US6432992 Use of riluzole or its salts for the prevention and treatment of adrenoleukodystrophy
08/13/2002US6432991 Methods of treatment using MAO-A and MAO-B inhibitors such as L-deprenyl
08/13/2002US6432989 Use of CRF antagonists to treat circadian rhythm disorders
08/13/2002US6432988 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine
08/13/2002US6432987 Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor action
08/13/2002US6432986 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
08/13/2002US6432985 4-benzyl-1-(2-(p-hydroxyphenoxy)ethyl)piperidine-3,4-diol; preparation from 1-(2-haloethoxy)-4-benzyloxybenzene and 4-benzylpiperidine-3,4-diol
08/13/2002US6432984 Cannabinoid receptor antagonists; treatment of obesity, drug addiction, alcholism, psychological, and eating disorders
08/13/2002US6432983 Treating estrogen-dependent cancer, endometriosis, osteoporosis, post-menopausal disorders and hyperlipidemia; restenosis inhibitors
08/13/2002US6432982 Benzothiophenes, and formulations and methods using same
08/13/2002US6432980 Aliphatic amine substituted piperidyl diaryl pyrrole derivatives as antiprotozoal agents
08/13/2002US6432979 Administering synergistic mixture of non-steroidal antiinflammatory agent and epidermal growth factor receptor kinase inhibitor comprising 3-cyanoquinoline derivative
08/13/2002US6432977 Salts of quinoline derivatives as NK3 antagonists
08/13/2002US6432976 Analgesics; side effect reduction
08/13/2002US6432975 Aromatic alkylene azobicyclic compounds as nicotinic receptor antagonists; antidepressants; nervous system disorder treatment
08/13/2002US6432973 Polyoxyethylated hydroxyesters of rapamycin useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease.
08/13/2002US6432972 Desloratadine as non-sedating antihistamine, decongestant
08/13/2002US6432971 Method of prevention of prostatic carcinoma with 17β-N-monosubstituted-carbamoyl-4-aza-5α-androst-1-en-3-ones
08/13/2002US6432970 Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
08/13/2002US6432968 Immunosuppressants for patients with cancer, autoimmune diseases, and viral infections
08/13/2002US6432967 Enema and enterically-coated oral dosage forms of azathioprine
08/13/2002US6432966 Antiviral combinations
08/13/2002US6432962 Antiinflammatory agents
08/13/2002US6432961 Method for preventing the onset of asthma
08/13/2002US6432957 Piperazine derivative
08/13/2002US6432956 Azapirone compound
08/13/2002US6432955 Heterocyclic derivatives and their use as antithrombotic agents
08/13/2002US6432954 Central nervous system disorders
08/13/2002US6432952 Central nervous system disorders; antiinflammatory agents
08/13/2002US6432950 Method for inhibiting neoplastic cells and related conditions by exposure to benzothienopyrimidine derivatives
08/13/2002US6432949 Amide derivatives useful as inhibitors of the production of cytokines
08/13/2002US6432948 Use of 7-(2-oxa-5,8-diazabicylco[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of heliobacter pylori infections and associated gastroduodenal diseases
08/13/2002US6432947 N-heterocyclic derivatives as NOS inhibitors
08/13/2002US6432945 Dipeptide derivatives
08/13/2002US6432943 Method for treating sexual dysfunction
08/13/2002US6432942 In combination with a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb; for supplementing dietary chromium and facilitating absorption of essential metals
08/13/2002US6432941 Vanadium compounds for treating cancer
08/13/2002US6432940 Uses for androst-5-ene-3β, 17β-diol
08/13/2002US6432938 Nasal administering a steroid
08/13/2002US6432937 Treatment for joint inflammation
08/13/2002US6432935 Synergistic mixture of antibiotic, sulfadimidine and fungicide
08/13/2002US6432934 Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
08/13/2002US6432932 Method for inhibiting bone resorption
08/13/2002US6432931 Compositions and methods for inhibiting bone resorption
08/13/2002US6432929 Cartilage enhancing food supplements and methods of preparing the same
08/13/2002US6432928 Complexes and their compositions
08/13/2002US6432927 Compositions and methods for inducing gene expression
08/13/2002US6432923 Antiinflammatory agents; autoimmune diseases
08/13/2002US6432921 Oligopeptides
08/13/2002US6432918 Methods and compositions for optimization of oxygen transport by cell-free systems
08/13/2002US6432703 Isolated polynucleotide sequences
08/13/2002US6432684 Human nucleotide sequence encode a polypeptide for denaturing polyunsaturated fatty acid
08/13/2002US6432682 Substances KF-1040 and process for producing of the same
08/13/2002US6432681 Compositions for treating Escherichia coli urinary tract infections
08/13/2002US6432656 Detection of calcilytic compound for calcium receptor bearing cell
08/13/2002US6432452 Topical administering a 20-acetyl-ingenol-3-angelate obtained from plant extracts having preferential cytolysis for cancer cells; metallothionein gene promotors having chemical and heat resistance
08/13/2002US6432447 Core of fluvastatin, hydroxypropyl methyl cellulose and optionally other excipients, dosage form is color-stable during storage
08/13/2002US6432446 Non-arrhythmogenic metabolite of oxybutynin
08/13/2002US6432441 Throat soothing compositions
08/13/2002US6432438 Biodegradable vehicle and filler
08/13/2002US6432434 Administering lipoic or dihydrolipoic acid as neuroprotectants for nervous system disorders or traumas
08/13/2002US6432432 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles
08/13/2002US6432431 Steroid-containing cataplasms and process for producing the same
08/13/2002US6432423 Polyethylenimine modified with thiobutyrolactone (4-mercaptobutyric acid); pendant mercaptans are oxidized to form disulfide bonds
08/13/2002US6432422 Oil in water emulsion with maxacalcitol; improved skin absorption and heat stability
08/13/2002US6432415 Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
08/13/2002US6432413 Functional improvements in Fahr disease
08/13/2002US6432401 Administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist; use in hair graft procedures, for example
08/13/2002US6432396 Sterilization, medical devices, bactericide, fungicide, viricide: palladium or platinum complex having methine or imine group reacted with vinyl polymers, polyurethanes, or polyolefins; thermally induced phase separation membrane of
08/13/2002US6432389 High SPF nontacky/nongreasy UV-photoprotecting compositions comprising particulates of MMA crosspolymers
08/13/2002US6431874 Stop smoking method and composition
08/13/2002CA2269947C Covalent polar lipid conjugates for targeting
08/13/2002CA2216633C Synthesis of bis-indolylmaleimides
08/13/2002CA2212357C 10-deacetyl-14beta-hydroxybaccatine iii derivatives, a process for the preparation thereof and formulations containing them
08/13/2002CA2167524C Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders